JAGSONPAL PHARMACEUTICALS LTD

JAGSNPHARM BSE
JAGSNPHARM
JAGSONPAL PHARMACEUTICALS LTD BSE
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E

JAGSNPHARM financial statements: Overview

Financial summary of JAGSONPAL PHARMACEUTICALS LTD with all the key numbers

The current JAGSNPHARM market cap is 3.972B. The company's EPS TTM is 8.16, dividend yield is 0.66%, and P/E is 18.62.

Earnings
Next:
Income Statement
Balance Sheet
Cash Flow